Corticosteroids for all adult patients with community-acquired pneumonia?
<p>Corticosteroid therapy as adjunctive treatment in community-acquired pneumonia (CAP) is a promising but controversial subject. The potentially beneficial effect of corticosteroids is based on the ability of steroids to dampen an excessive inflammatory response that often occurs in patients...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2015-01-01
|
| Series: | Pneumonia |
| Subjects: | |
| Online Access: | https://pneumonia.org.au/index.php/pneumonia/article/view/690 |
| Summary: | <p>Corticosteroid therapy as adjunctive treatment in community-acquired pneumonia (CAP) is a promising but controversial subject. The potentially beneficial effect of corticosteroids is based on the ability of steroids to dampen an excessive inflammatory response that often occurs in patients with CAP. This excessive inflammatory response can cause damage to the lungs and other organs, and is associated with poor outcome.</p> |
|---|---|
| ISSN: | 2200-6133 |